A peptide derived from melanotransferrin delivers a protein-based interleukin 1 receptor antagonist across the BBB and ameliorates neuropathic pain in a preclinical model.
Saved in:
| Title: | A peptide derived from melanotransferrin delivers a protein-based interleukin 1 receptor antagonist across the BBB and ameliorates neuropathic pain in a preclinical model. |
|---|---|
| Authors: | Thom, George1 (AUTHOR), Tian, Mei-Mei2 (AUTHOR) meimei@bioasis.us, Hatcher, Jon P3 (AUTHOR), Rodrigo, Natalia1 (AUTHOR), Burrell, Matthew1 (AUTHOR), Gurrell, Ian3 (AUTHOR), Vitalis, Timothy Z4 (AUTHOR), Abraham, Thomas5 (AUTHOR), Jefferies, Wilfred A6 (AUTHOR), Webster, Carl I1 (AUTHOR), Gabathuler, Reinhard4 (AUTHOR) |
| Source: | Journal of Cerebral Blood Flow & Metabolism. Oct2019, Vol. 39 Issue 10, p2074-2088. 15p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 0271678X |
|---|---|
| DOI: | 10.1177/0271678X18772998 |
